“WTO ruling will drive up drug costs.” Canada’s research-based pharmaceutical companies out of the fray

Canada's generic drug manufacturers are cautiously optimistic in the wake of last week's decision by the Canadian government to appeal a World Trade Organization ruling that found Canada's patent protection laws too weak. The case was brought forward by the United States government, which success...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.


Already a Subscriber?

Get Fridays: Hill Life & People Newsletter

It’s all about the people: the latest on parliamentarians, political staff, and politicos.


By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy

MORE News

RELATED STORIES